7 December 20207 December 2020Vera Salus Ricerca has successfully completed a 1-year training at BioArk (Switzerland) aimed at polishing the business developmental plans of FlavOncology, its proprietary drug platform for the cure of cancer patients.
2 November 20202 November 2020Vera Salus Ricerca Srl, in collaboration with the Sicilian Zooprophylactic Institute and the National Reference Center for Toxoplasmosis, just published a research study in the Journal of Food Protection concerning the safety of novel foods with respect to Toxoplasma gondii infections. The paper, entitled “Edible insects and Toxoplasma gondii: is it something we need to be concerned about?”, provides evidences of the risk for public health poised by Toxoplasma gondii entering the human food chain through contaminated novel edible foods and causing toxoplasmosis disease in exposed individuals